FDA Drug Recalls

Recalls / Class II

Class IID-0342-2022

Product

MAJOR, Fexofenadine Hydrochloride tablets, 12HR, 60mg Antihistamine, 100 count bottle, Distributed by Major Pharmaceuticals 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152. Made in the Czech Republic, NDC 0904-6979-60 UPC 3 09046 97960 9

Affected lot / code info
Lot 0GR0445, Exp 1/31/2022; 0LR0361, Exp 4/30/2022; 1AR0558, Exp 7/31/2022

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Recalling firm

Firm
Perrigo Company PLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
65,796 containers
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-07-27
FDA classified
2022-01-05
Posted by FDA
2022-01-12
Terminated
2022-11-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0342-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls